Miromatrix Medical Stock Current Valuation
Valuation analysis of Miromatrix Medical helps investors to measure Miromatrix Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Miromatrix Medical Company Current Valuation Analysis
Miromatrix Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Miromatrix Medical Current Valuation | 80.11 M |
Most of Miromatrix Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Miromatrix Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Miromatrix Medical has a Current Valuation of 80.11 M. This is 99.44% lower than that of the Biotechnology sector and 98.28% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.52% higher than that of the company.
Miromatrix Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Miromatrix Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Miromatrix Medical could also be used in its relative valuation, which is a method of valuing Miromatrix Medical by comparing valuation metrics of similar companies.Miromatrix Medical is currently under evaluation in current valuation category among its peers.
Miromatrix Fundamentals
| Return On Equity | -1.14 | |||
| Return On Asset | -0.56 | |||
| Operating Margin | (593.69) % | |||
| Current Valuation | 80.11 M | |||
| Shares Outstanding | 27.42 M | |||
| Shares Owned By Insiders | 23.95 % | |||
| Shares Owned By Institutions | 25.75 % | |||
| Number Of Shares Shorted | 11.66 K | |||
| Price To Book | 5.98 X | |||
| Price To Sales | 97.02 X | |||
| Revenue | 953.47 K | |||
| Gross Profit | (466.93 K) | |||
| EBITDA | (29.91 M) | |||
| Net Income | (29.96 M) | |||
| Cash And Equivalents | 32.67 M | |||
| Cash Per Share | 1.56 X | |||
| Total Debt | 3.55 M | |||
| Debt To Equity | 0.1 % | |||
| Current Ratio | 9.09 X | |||
| Book Value Per Share | 0.57 X | |||
| Cash Flow From Operations | (26.68 M) | |||
| Short Ratio | 0.03 X | |||
| Earnings Per Share | (1.14) X | |||
| Target Price | 3.13 | |||
| Number Of Employees | 76 | |||
| Beta | 0.015 | |||
| Market Capitalization | 92.95 M | |||
| Total Asset | 34.76 M | |||
| Retained Earnings | (104.01 M) | |||
| Working Capital | 22.36 M | |||
| Z Score | 9.47 | |||
| Net Asset | 34.76 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Miromatrix Stock
If you are still planning to invest in Miromatrix Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Miromatrix Medical's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |